Vigil Neuro jobs and careers
Cambridge, MA, United States
About Vigil Neuro
Vigil Neuroscience is the world’s first microglia-focused therapeutics company. Their purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain’s immune system. They are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and their families.
Founded in 2020 by Ivana Magovčević-Liebisch.
- Founded
- 2020
- Employees
- 125
- Total funding
- $180M
- Headquarters
- Cambridge
Leadership
The top of Vigil Neuro's org chart, with how many people report into each leader.
David Gray
Chief Science Officer
22 reports
Weeteck Yeo
SVP, Strategic Operations
7 reports
Jennifer Ziolkowski
CFO
6 reports
Cynthia Cassandro
Vice President, Patient Advocacy
1 report
Brenda Duane
Chief People Officer
1 report
Charles Democko
SVP Regulatory And Quality
1 report
Leah Gibson
Vice President, Investor Relations & Communications
Kevin Durfee
VP & Head, Information Technology
Andreas Meier
SVP, Clinical & Medical Sciences
13 reports
Berkley Lynch
VP, Biology
5 reports
Jonathan Houze
Head Of Chemistry
1 report
April Effort
Vp, Head Of Corporate Development
2 reports
Sofia Zhidro
Senior Director Quality
1 report
Rizwan Manzer
Director, CMC & Technical Operations
Sharon Morani
Senior Director, Facilities & Operations
Pam Meneses
Corporate Controller
4 reports
Board
Suzanne Bruhn
Director
Mary Thistle
Director
Ole Isacson
Scientific Advisor
Stefan Vitorovic
Director
Bradley Hyman
Scientific Advisor
John Dunlop
Scientific Advisor
Jobs at Vigil Neuro
No open positions right now. Explore more companies on TheJobsMap.